Plant, Jane and Tidey, Gill, 2002. The Plant Programme. Paperback edition. Virgin Books; Plant, Jane and Tidey, Gill, 2005. Eating for Better Health. Virgin Books.

Kradjian, Robert D., 1994. Save Yourself from Breast Cancer. Berkley Publishing.

Plant, Jane and Tidey, Gill, 2003. Understanding, Preventing and Overcoming Osteoporosis. Virgin Books.

Под хемопревентивным действием понимают способность вещества предупредить развитие рака либо затормозить его. – Примеч. ред.

Selected causes of death: by gender and age. Office for National Statistics; General Register Office for Scotland; Northern Ireland Statistics and Research Agency. 1997.

Deaths: selected causes (International Classification) and sex, 1971 onwards (England and Wales): Health Statistics Quarterly, 04. 1998

http://who-pcc.iarc.fr/

Trichopoulos, Dimitrios, Li, Frederick, P., and Hunter, David J, 1996. What Causes Cancer? Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 80–85.

Plant, Jane A. and Moore, P. J., 1979. Geochemical mapping and interpretation in Britain. Phil. Trans. Roy. Soc., London, B288, pp. 95-112.

Plant, Jane A., Smith, D., Smith, B. and Williams, L., 2000. Environmental Geochemistry at the Global Scale. Geological Society Special Issue.

Dewey, John F., 1999. Geoscientist 9, 6 June, Society Awards, pp. 2–4.

Blair's war on cancer is a sham, say top doctors. Independent On Sunday. 14 November 1999.

Rennie, J, and Rusting, R., 1996. Making Headway Against Cancer. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 56-9.

Peto, R. and others, 2000. Smoking, Smoking Cessation and Lung Cancer in the UK since 1950. British Medical Journal, 321, 323-9.

Raleigh, V. S., 1999. World Population and Health in Transition. British Medical Journal, 319, 981–984.

Packham, D. E., 1999. Impacts of Commercialisation and Privatisation on Capabilities for Scientific Advice, Oracles or Scapegoats? IPMS Conference notes, October. See also: Packham, David and Tasker, Mary, 1997. Industry and the academy – a Faustian contract. Industry and Higher Education, April, 85–90.

World Health Organization's International Agency for Research on Cancer website: http://who-pcc.iarc.fr/

Physicians Committee for Responsible Medicine: PCRM Update of Winter 1991.

Cancer Research Campaign Factsheet 6.2, 1996.

Уинстон Черчилль был подвержен частым приступам депрессии – пожалуй, самого главного его врага. Безысходная тоска охватывала Черчилля в периоды мучительных, неотвязных кризисов, и тогда ему казалось, что «огромный черный пес», как он говорил, преследует его по пятам. – Примеч. ред.

Депрессия – очень распространенное явление: за год о симптомах депрессии сообщают более двух миллионов человек. Если вы страдаете депрессией, постарайтесь разобраться, не вызвана ли она реальными проблемами? В этом случае обратитесь за практической помощью и советом. Гражданское консультационное бюро предоставляет бесплатные советы по финансовым и юридическим вопросам, а «Самаритяне» или ваши друзья помогут разобраться с эмоциональными трудностями и научить с ними справляться. Хорошие советы нередко дает MIND, благотворительная организация, занимающаяся душевным здоровьем. В одной из ее недавних брошюр о депрессии (MIND 1999. Depression – don't let it get you down. MIND and Pharmacy Healthcare; Mind Information, 15–19 Broadway, London E15 4BQ; Pharmacy Healthcare scheme, 1 Lambeth High Street, London SE1 7JN) утверждается, что «таблетки для симптомов, а разговор – для решения проблем». Вы должны питаться качественной, разнообразной пищей, поскольку в ней нуждается мозг, не употреблять искусственные органофосфаты (см. главу 6) и алкоголь в больших количествах. Если у вас серьезная депрессия, обратитесь за медицинской помощью. Хотя у современных антидепрессантов есть побочные эффекты, лучше иметь их, чем страдать от тяжелой депрессии.

The Times, 7 February 1998.

Cox, Peter and Brusseau, Peggy, 1992. Superliving: A Beginner's Guide to Medspeak, Vermillion.

Скрининг (от англ. screening, «просеивание») – общее название методов специальных проверок, обследований, применяемых в медицине, биохимии, а также в бизнесе и т. п. В медицине под скринингом понимают проведение простых и безопасных исследований больших групп населения с целью выделения групп риска развития той или иной патологии. – Примеч. ред.

Boots the Chemist, 1998. Breast Awareness – an essential guide. Be enlightened, not frightened. Published in association with the charity Breast Cancer Care.

Sunday Correspondent, 26 November 1989.

Alternative Therapy, British Medical Association, 1986.

New Scientist, 27 August 1987.

Vickers, A. and Zollman, C., 1999. ABC of complementary medicine: Acupuncture. British Medical Journal, 9 October, 973–976.

Дополнительную информацию о контроле боли при раке, в том числе на поздних стадиях, см. в статье Кэтлин М. Фоли в Scientific American, сентябрь, 1996.

Gerson, M., 1958. A Cancer Therapy: Results of Fifty Cases, Gerson Institute, California. Forbes, Alec, 1984. The Bristol Diet, Century.

Greenwald, P., 1996. Chemoprevention of Cancer. Scientific American, Special issue: What you need to know about Cancer, vol. 275, 3, pp. 96-100; and see also the World Health Organisation's International Agency for Research on Cancer website; http://who-pcc.iarc.fr/ and see also the British National Formulary, 1998.

Section on cytotoxic (cell poisoning) drugs in the British National Formularv, 1998.

Weinberg, Robert A., 1996. How Cancer Arises. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 62–70.

Pollack, M. N. and others, 1998. IGF-1 Risk Factor for Prostate Cancer. Science, 279, 563–566. Pollack, M. N., Huynh, H. T., and Lefebvre, S. P., 1992. Tamoxifen reduces serum insulin-like growth factor 1 (IGF-1). Br. Cancer Res. Treat, 22, 91-100. Pollack, M. N., Polychronakos, C., Yousefi, S., and Richard, M., 1988. Characterisation of insulin-like growth factor-1 (IGF-1) receptors of human breast cancer cells. Biochem Biophy Res. Commun, 154, 1, 326–331.

Oliff, Alien, Gibbs, Jackson, B. and McCormick, Frank, 1996. New Molecular Targets for Cancer Therapy. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 144–149.

Weinberg, Robert A., 1996, How Cancer Arises. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 62–70.

Jain, R. K., 1994. Barriers to Drug Delivery in Solid Tumours. Scientific American, July, 271 (l), pp. 58–65.

Trichopoulos, Dimitros, Li, Frederick, P. and Hunter, David J., 1996. What Causes Cancer? Scientific American, Special Issue, What you need to know about Cancer. September 275, 3, 80–85.

Boots the Chemist, 1998. Breast Awareness – an essential guide, Be enlightened, not frightened. Published in association with the charity Breast Cancer Care.

Trichopoulos, Dimitrios, Li, Frederick, P. and Hunter, David J., 1996. What Causes Cancer Scientific American, Special Issue, What you need to know about Cancer. September, 275, 3, 80–85.

Holland, J. C., 1996. Cancer's Psychological Challenges. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 158–161.

http://www.who.int/nut/malnutrition_worldwide.htm

Cancer Incidence in Five Continents, 1997. Vol VII, published by the IARC (International Agency for Research on Cancer).

Cancer Incidence in Five Continents. 1997. Vol. VII, published by the IARC (International Agency for Research on Cancer).

Kliewer, E. V. and Smith, K. R., 1995. Breast cancer mortality among immigrants in Australia and Canada. Journal of Natl Cancer Institute, 87, 15, 1154–1161. See also Cancer Research Campaign, 1996, Factsheet 6.2, Breast Cancer – UK.

Campbell, T. C. and Junshi, C., 1994. Diet and chronic degenerative disease perspectives from China. Am. J. Clin. Nutr., 59, Suppl., 11 535-11 615,

Rohan, T. E., McMichael, A. J. and Bagbursi, P. A., 1988. A population-based case control study of diet and breast cancer in Australia. Am. J. Epidemic, 128, 478–489; Howe, G. R., Hirobata, T., Hislap, T. G. and others. 1990. Dietary factors and risk of breast cancer, combined analysis of 12 case-control studies. J. Natl Cancer Inst., 8, 561–569; Willet, Walter C. and others, 1987. Dietary fat and the risk of breast cancer. N. Engl J. Med., 316, 22–28; Jones, D. Y., Schatzkin, A., Green, S. B. and others. 1987. Dietary fat and breast cancer in the National Health and Nutrition Examination Survey epidemiological follow-up study. J. Natl Cancer Inst., 79, 465–471.

Trichopoulos, Dimitrios, Li, Frederick, P. and Hunter, David J., 1996. What Causes Cancer? Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 80–85.

Cramer, D. W. and others, 1989. Galactose consumption and metabolism in relation to the risk of ovarian cancer. Lancet, 2, 66–71.

Stocks, P., 1970. Breast cancer anomalies. British Journal of Cancer, 24, 633–643.

Maruchi, N. and others, 1977. Relation of food consumption to cancer mortality in Japan, with special reference to international figures. Gann, 1977; 68, 1-13.

Cox, Peter and Brusseau, Peggy, 1995. Life Points For Kids. Bloomsbury.

Statistical Abstracts of the US, 1994 edition.

Willett, W. C. and others, 1996. Strategies for Minimizing Cancer Risk. Scientific American, Special Issue, What you need to know about Cancer, 275:3, pp, 88–95.

Akre, James, ed., 1989. Infant feeding: the physiological basis. WHO Bulletin, OMS Supplement, Vol. 67, and Lawrence, Ruth A., 1994. Breastfeeding: A guide for the medical profession. Fourth Edition, Mossby, USA.

Lawrence, Ruth A., 1994. Breastfeeding: A guide for the medical profession. Fourth Edition, Mossby, USA.

Lawrence, Ruth A., 1994. Breastfeeding: A guide for the medical profession. Fourth Edition, Mossby, USA.

Akre, James, Ed., 1989. Infant feeding: the physiological basis. WHO Bulletin, OMS Supplement, Vol. 67; and Lawrence, Ruth A., 1994. Breastfeeding: A guide for the medical profession. Fourth Edition, Mossby, USA.

Akre, James, Ed., 1989. Infant feeding: the physiological basis. WHO Bulletin, OMS Supplement, Vol 67, and Lawrence, Ruth A., 1994. Breastfeeding: A guide for the medical profession. Fourth Edition, Mossby, USA.

Akre, James Ed., 1989. Infant feeding: the physiological basis. WHO Bulletin, OMS Supplement, Vol. 67, and Lawrence, Ruth A., 1994. Breastfeeding: A guide for the medical profession. Fourth Edition, Mossby, USA.

American Academy of Pediatrics Committee on Nutrition (1992). The use of whole cows' milk in infancy. Pediatrics, 89, 1105–1109.

Anyon, C. P. and Clarkson, K. G., 1971. A cause of iron-deficiency anaemia in infants. N. Z. Med. J., 74, 24–25.

Clyne, P. S. and Kulczycki, A. 1991. Human breast milk contains bovine IgG. Relationship to infant colic? Pediatrics, 87(4), 439–444. Wilson, J. F., Lahey, M. E. and Heiner, D. C., 1974. Studies on iron metabolism. Further observations on cow's milk-induced gastrointestinal bleeding in infants with iron-deficiency anaemia. J. Pediatr., 84, 335–344.

Pugh, R. H., 1981. Allergy to Cows' Milk Protein. Health Visitor, Vol. 54, 231–233.

Scon, F. W., 1990. Cow milk and insulin-dependent diabetes mellitus: is there a relationship? Am. J. Clin. Nutr., 51, 489–491.

Bahna, S. L., 1987. Milk allergy in infancy. Ann Allergy, 59, 131.

Dunea, G., 1982. Beyond the Etheric. Br. Med. J., 285, 428–429.

Kretchmer, N., 1981. The Significance of lactose intolerance. In: Paige, D. M. and Bayless, T. M., Eds., Lactose Digestion: Clinical and nutritional implications, Johns Hopkins University Press.

Chiodini, R. J. and Hermon-Taylor, J., 1993. The thermal resistance of Mycobacterium paratuberculosis in raw milk under conditions simulating pasteurisation. J. Vet. Diagn. Invest., 5, 629–631 and Grant, I. R., Ball, H. J., and Rowe, M. T., 1996. Inactivation of Mycobacterium paratuberculosis in cows' milk at pasteurisation temperatures. Appl. And Env. Microbiology, 62, 631–636.

The Institute of Food Science & Technology Position Statement, 1998. Food Science Of Technology Today. 12 (4), 223–228, September, http://www.ifst.org/hottop23.html

Financial Times for the weekend 20–21 November 1999.

The Institute of Food Science & Technology Position Statement. http://www.ifst.org/hottop2.html. Hard copies available from IFST, 5 Cambridge Court, 210 Shepherds Bush Road, London, W6 7NJ.

EU Directive 70/524 February 1999.

US FDA websites: http://vm.cfsan.fda.gov/~ear/m190-11.html; http://vm.cfsan.fda.gov/~ear/

Ingersoll, Bruce, 1990. Technology and Health: FDA Detects Drugs in Milk but Fails to Confirm Results. Wall Street Journal, 6 February p. 86; Ingersoll, Bruce, 1990. Politics and Policy: GAO Says FDA Can't Substantiate Claims About Milk. Wall Street Journal, 21 November p. A16; and Ingersoll, Bruce, 1990. Technology & Health: FDA Plans a Nationwide Test of Milk for Antibiotics, Other Drug Residues. Wall Street Journal, 28 December p. 10.

European Commission, Scientific Committee on Veterinary Measures relating to Public Health, 1999. Report on Public Health Aspects of the Use of Bovine Somatotropin, 15–16 March.

Cutwater, J. L. and others, 1997. Dairy Products and Breast Cancer: the IGF-1, estrogen and bGH hypothesis, Medical Hypotheses, 48, 453–461.

ДДТ (дихлордифенилтрихлорэтан) – один из самых известных пестицидов.

The Guardian, 13 July 1999.

McCusker, R. H., 1998. Controlling insulin-like growth factor activity and the modulation of insulin-like growth factor binding protein and receptor binding. J. Dairy Sci., 81, 1790–1800.

Гормон роста, или соматотропин, структурно различается у разных видов животных, поэтому его называют согласно виду, которому он принадлежит, – бычий, свиной или, например, человеческий.

The Institute of Food Science & Technology Position Statement http://www.easynet.co.uk/ifst/hottop8a.htm

Eppard, P. J. and others, 1985. Effect of dose of bovine growth hormone on milk consumption: alpha-lactalbumin, fatty acids and mineral elements. J. Dairy Science Vol. 68 (11), pp. 3047–3054. See also Cohick, W. S. and others, 1992. Regulation of insulin-like growth factor-binding proteins in serum and lymph of lactating cows by somatotropin. Endocrinology, 130(3), pp. 1508–1514.

Mepham, T. B. and others, 1994. Safety of Milk from Cows Treated with Bovine Somatotropin. Lancet, 334, November 19, 1445–1446 and Mepham, T. B. and Schonfield, P. N., 1995. Health Aspects of BST Milk, prepared for the International Dairy Federation Nutrition Week conference in Paris, France, June 1995.

Simpson and others, http://www.nal.usda.gov/ttic/tekran/glimpse/data/000007/75/0000077539.html

Miller, M. A., Hildebrand, J. R., White, T. C., Hammond, E. G., Madson, K. S., and Collier, R. J., 1989. Determination of insulin-like growth factor-1 (IGF-1) concentrations in raw pasteurised and heat treated milk. Journal of Dairy Science, 72, Supplement 1, 186–187.

Hankinson, Susan E. and others, 1998. Circulating concentrations of insulin-like growth factor-1 and risk of breast cancer. Lancet 351, 9113, 9 May, 1393–1396.

Chan and others, 1998. Plasma IGF-1 and Prostate Cancer Risk; A Prospective Study. Science, 279, January.

Pollack, M. N., Huynh, H. T. and Lefebvre, S. P., 1992. Tamoxifen reduces serum insulin-like growth factor 1 (IGF-1). Br. Cancer Res. Treat, 22, 91-100.

Pollack, M. N. and others, 1998. IGF-1 Risk Factor for Prostate Cancer. Science, 279, 563–566.

Chan and others, 1998. Plasma IGF-1 and Prostate Cancer Risk: A Prospective Study. Science, 279, January.

Holly, Jeff, 1998. Insulin-like growth factor-1 and new opportunities for cancer prevention. Lancet, 351, 9113, 9 May, 1373–1375.

Epstein, Samuel S., 1996. Unlabelled Milk from Cows Treated with Biosynthetic Growth Hormones: A Case of Regulatory Abdication. International Journal of Health Services, 26, 1, 173–185.

Outwater, J. L., Nicholson A. and Bernard N., 1997. Dairy products and breast cancer: the IGF-1, estrogen, and bGH hypothesis. Medical Hypotheses 48, 453–461.

Leonard, Rodney E., 1995. Codex at the Crossroads: Conflict on Trade Health. Nutrition Week, Vol. 25, № 26, 14 July, pp. 4–5, Nutrition Week is published by the Community Nutrition Institute, 910 17^>th Street, N. W., Suite 413, Washington DC 20006.

The European Commission. Health and Consumer Protection. Scientific Committee on Veterinary Measures relating 10 Public Health – Outcome of discussions. http://europa.eu.mt/comm/dg24/health/sc/scv/out19_en.html

D'Ercole, J. A., Underwood, L. E. and Van Wyk, J. J., 1977. Serum Somatomedin-C in hypopituaritism and in other disorders of growth. J. Pediatr., 90, 3, 375–381. See also Cullen, K. J. and others, 1990. Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Research, vol. 50, pp. 48–53.

De Leon, D. D., Wilson, D. M., Powers, M. and Rosenfeld, R. G., 1992. Effects of insulin-like growth factors (IGFs) and IGF receptor antibodies on the proliferation of human breast cancer cells. Growth Factors, 6, 327–336.

Peyrat, J. P., Bonneterre, J. and Hecquet, B. and others, 1993. Plasma insulin-like growth factor 1 (IGF-1) concentrations in human breast cancer. Eur. J. Cancer, 29A, 4, 492–497.

Peyrat, J. P., Bonneterre, J. and Hecquet, B. and others, 1993. Plasma insulin-like growth factor 1 (IGF-1) concentrations in human breast cancer. Eur. J. Cancer, 29A, 4, 492–497.

Musgrove, E. A. and Sutherland, R. I., 1993. Acute effects of growth factors on T471 breast cancer cell cycle progression, Eur. J. Cancer, 29A, 16, 2273–2279.

Heldrin, C. N. and Westermark, B., 1984. Growth factors: mechanism of action and relation to oncogenes. Cell, 37:9, 20.

Macaulay, V. M., 1992. Insulin-like growth factors and cancer. Br. J. Cancer, 65, 311–320.

Underwood, L. E., D'Ercole, J. A. and Van Wyk, J. J., 1980. Somatomedin-C and the assessment of growth. Ped. Clin. N. Amer., 27, 4, 771–782, and Perdue, J. F., 1984. Chemistry, structure and function of insulin-like growth factors and their receptors: a review. Can J. Biochem Cell Bio., 62, 1237–1245.

Outwater, J. L., Nicholson, A, and Barnard, N., 1997. Dairy products and breast cancer; the IGF-1 estrogen, and bGH hypothesis. Medical Hypotheses, 48, 453–461.

The European Commission. Health and Consumer Protection. Scientific Committee on Veterinary Measures relating 10 Public Health – Outcome of discussions. http://europa.eu.int/comm/dg24/health/sc/scv/out19_en.html

Council on Scientific Affairs, American Medical Association, Biotechnology and the American Agricultural Industry, 1991. Journal of the American Medical Association (JAMA), 265, 11, 20 March, p. 1433.

Mepham, T. B. and Schonfield, P. N., 1995. Health Aspects of BST Milk, prepared for the International Dairy Federation Nutrition Week conference in Paris, France, June 1995.

Challacombe. D. N. and Wheeler, E. E., 1994. Safety of milk from cows treated with bovine somatotropin. Lancet, 344, 17 September, p. 815.

Sell, C., Rubin, R. and Baserga, R., 1995. Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. Cancer Research, Jan 15, 55(2), 303–306.

Burton, Jeanne L. and others, 1994. A review of bovine growth hormone, Canadian Journal of Animal Science, 74, 167–201.

Xian, C., 1995. Degradation of IGF- 1 in the Adult Rat Gastrointestinal Tract is limited by a Specific Antiserum of the Dietary Protein Casein. Journal of Endocrinology, 146, 2, 1 August, p. 215, and Thornburg, W. and others, 1984. Gastrointestinal absorption of epidermal growth factor in suckling rats. American Journal of Physiology, 246, G80-G85.

Outwater, J. L., Nicholson, A. and Barnard, N., 1997. Dairy products and breast cancer; the IGF-1 estrogen, and bGH hypothesis. Medical Hypotheses, 48, 453–461.

Harasuchi, S., Good, R. A., Engelman, R. W. and Day, N. K., 1992. Human prolactin regulates transfected MMTV LTR-directed gene expression in a human breast-carcinoma cell line through synergistic interaction with steroid hormones. Int J. Cancer, 52, 923–933.

Clevenger, C, V., Chang, W. F., Ngo, W., Pasha, T. L., Montone, K. T. And Tomaszewski, J. E., 1995. Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop. Am. J. Pathol., 146, 695–705.

Vonderhaar B. K., 1989. Estrogens are not required for prolactin induced growth of MCF-7 human breast cancer cells. Cancer Lett, 47, 105–110.

http://www.shef.ac.uk/uni/academic/a-c/csi/1997/pir2.html

Lochnan, H. A. and others, 1995. Functional activity of the human prolactin receptor and its ligands. Mol. Cell. Endocrinol, 114, 91–99.

http://mammary.nih.20v/reviews/tumorigenesis/Vonderhaar001/slides/introduction.html

Struman, I., Bentzien, F., Lee, H., Mainfroid, V., D'Angelo, G., Goffin, V., Weiner, R. I. and Martial, J. A., 1999. Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis. Proc. Natl. Acad. Sci. USA, 96, 1246–1251.

http://www.eurekalert.org/releases/upmc-bcc061699.html

Lawrence R., 1994. Breastfeeding – A Guide to the Medical Profession, Fourth edition, Mossby, USA.

http://www.inter-medico.com/prolactin.html

Lawrence, R., 1994. Breastfeeding: A Guide for the Medical Profession. Fourth edition, Mossby, USA.

Poggi, S. H., Skinner, H., Catherine W. and others, 1998. Using scanning electron microscopy to study mineral deposits in breast tissues. American Mineralogist, 83, 1122–1126.

Lee, J. R., 1996. Natural Progesterone. John Carpenter Publishing, Oxfordshire, 113 pp.

Wolford, S. T. and Argoudelis, C. J., 1979. Measurement of Estrogens in Cow's Milk, Human Milk and Dairy Products. J. Dairy Sci., 62(9), 1458–1463.

Outwater, J. L., Nicholson, A. and Barnard, N., 1997. Dairy products and breast cancer; the IGF-1 estrogen, and bGH hypothesis. Medical Hypotheses, 48, 453–461.

The European Commission. Health and Consumer Protection. Scientific Committee on Veterinary Measures relating to Public Health – Outcome of discussions. 1999, Report on Public Health Aspects of the Use of Bovine Somarotropin. http://europa.eu.int/comm/dg24/health/sc/scv/out19_en.html

Allen, N. E., and others, 2000. Hormones and Diet: Low Insulin-like Growth Factor-1 but Normal Bioavailable Androgens in Vegan Men. Brit. J. Cane., 83 (1), 95–97.

Веганство (веганизм, англ. Veganism) – наиболее последовательная форма вегетарианства, строго вегетарианский образ жизни, исключающий использование продуктов, связанных с эксплуатацией и убийством животных. Веганы – строгие вегетарианцы, исключающие из своего рациона все продукты животного происхождения, включая мясо, рыбу, яйца, молоко, молочные продукты и иногда мед. Веганы не используют мех и кожу животных, выступают против убийства животных ради опытов и развлечений. – Примеч. ред.

Chan, J. C., and others, 1998. Plasma TGF-1 and Prostate Cancer Risk: A Prospective Study. Science 279, January.

Kradjian, R. D., 1994. Save Yourself from Breast Cancer, Berkley Books, New York.

Кормовая патока, побочный продукт сахарного производства; сиропообразная жидкость темно-бурого цвета со специфическим запахом. В США и Канаде используется в кулинарии как сироп. – Примеч. ред.

Wright, K., 1996. A plea for prevention. Scientific American, September. (Inset p.99 in article by Greenwald 1996, see below ref. 20).

Collaborative Group on Hormonal Factors in Breast Cancer, 1996. Lancet, 347, 1713–1727.

http://www.who.int/nut/malnutrition_worldwide.html

The Times, 2 November 1999.

Riggs, B. L., Wahner, H. W., Melton, L. J. 3rd, Richelson, L. S., Judd, H. L. And O'Fallon, W. M., 1987. Dietary calcium intake and rates of bone loss in women. J. Clin. Invest., Oct, 80, 4, pp. 979–982.

Hegsted, D. M., 1986. Calcium and Osteoporosis. J. Nutr., 116, 2316–2319.

Kim, J. B., 1990. Fractured truths. Bestways v 18, n2, p. 26(7).

Kim, J. B., 1990. Fractured truths. Bestways v 18, n2, p. 26(7).

http://www.who.int/nut/malnutrition_worldwide.html

Dietary Reference Values for Food Energy and Nutrients for the United Kingdom. Department of Health, 1991.

Dietary Reference Values for Food Energy and Nutrients for the United Kingdom. Department of Health, 1991. P. 139, table 22.2.

Havaia, S. and Dwyer, J., 1988. Position of the American Dietetic Association: Vegetarian Diets – technical support paper. J. Am. Diet Assoc, 88:3 352–355.

Barnard, N., 1993. Food for life, Harmony Books.

'Research Advances in Osteoporosis', 1990. Conference by the National Osteoporosis Foundation, the National Institutes of Health, and the American Society of Bone and Mineral Research, Arlington, Virginia, USA February.